TY - JOUR T1 - MHRA DOAC safety reminder JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 150 LP - 150 DO - 10.1136/dtb.2020.000047 VL - 58 IS - 10 A2 - , Y1 - 2020/10/01 UR - http://dtb.bmj.com/content/58/10/150.abstract N2 - Review of: Medicines and Healthcare products Regulatory Agency. Direct-acting oral anticoagulants (DOACs): reminder of bleeding risk, including availability of reversal agents. Drug Safety Update 2020;13(11):1 ER -